Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Demonta D. Coleman
Observed names:
Demonta Coleman,
Demonta D Coleman
Institution:
Texas A&M University
Observed institution:
Texas A&M University
ORCID:
0000-0002-5806-1813
Observed ORCID:
0000-0002-5806-1813
OpenAlex ID:
A5044750167
Works
12
Awards
1
Discovery of First-in-Class PROTAC Degraders of SARS-CoV-2 Main Protease
2024
·
Yugendar R. Alugubelli
, Jing Xiao
, et al.
·
Journal of Medicinal Chemistry
·
96
SARS-CoV-2 Main Protease Inhibitors That Leverage Unique Interactions with the Solvent Exposed S3 Site of the Enzyme
2024
·
Lauren R. Blankenship
, Kai S. Yang
, et al.
·
ACS Medicinal Chemistry Letters
·
18
An Azapeptide Platform in Conjunction with Covalent Warheads to Uncover High-Potency Inhibitors for SARS-CoV-2 Main Protease
2023
·
Kaustav Khatua
, Yugendar R. Alugubelli
, et al.
·
Antiviral Research
·
18
PDF
An amber-encoding helper phage for more efficient phage display of noncanonical amino acids
2023
·
Joshua Trae Hampton
, Chia-Chuan Dean Cho
, et al.
·
Nucleic Acids Research
·
15
PDF
Ubiquitin Azapeptide Esters as Next-Generation Activity-Based Probes for Cysteine Enzymes in the Ubiquitin Signal Pathway
2025
·
Saibal Chanda
, Sandeep Atla
, et al.
·
Journal of the American Chemical Society
·
14
PDF
2-Cyanopyrimidine-Containing Molecules for N-Terminal Selective Cyclization of Phage-Displayed Peptides
2025
·
J. Trae Hampton
, Connor R. Dobie
, et al.
·
ACS Chemical Biology
·
12
PDF
Nicotine-Inspired, De Novo-Designed SARS-CoV-2 Main Protease Inhibitors Reveal Unique Chemistry for Covalently Conjugating Both Cysteine and Histidine Residues in the Catalytic Dyad
2026
·
Sandeep Atla
, Veerabhadra Vulupala
, et al.
·
Journal of the American Chemical Society
·
3
PDF
From nicotine to SARS-CoV-2 antivirals with potent in vivo efficacy and a broad anti-coronavirus spectrum
2026
·
Kaustav Khatua
, Sandeep Atla
, et al.
·
Nature Communications
·
3
PDF
A Refined Search of SARS-CoV-2 Main Protease Inhibitors as COVID-19 Antivirals
2026
·
Veerabhadra R. Vulupala
, Yugendar R. Alugubelli
, et al.
·
Journal of Medicinal Chemistry
PDF
A proximity-driven and regioselective peptide bicyclization (PReP-Bicyc) approach for phage display libraries
2026
·
Guoqing Jin
, Yifan Shi
, et al.
·
Nature Communications
PDF
Exploration of Nirmatrelvir Derivatives as Optimized SARS‐CoV‐2 Antivirals
2026
·
Yugendar R. Alugubelli
, Veerabhadra R. Vulupala
, et al.
·
ChemMedChem
High-Throughput Screening Identifies Covalent Inhibitors with Unique Chemistry and Binding Modes for SARS-CoV-2 Main Protease
2026
·
Sandeep Atla
, Kai S. Yang
, et al.
·
JACS Au
PDF
Show more works
View as search
Works count:
12
Citation count:
179
H-index:
6
I10-index:
6
Year
Topic
Type